Tuesday, January 27, 2015

Question of the Day January 27, 2015 If there is so much confusion about the DQSA and office use why are state boards of pharmacies adopting and following the federal law? Isn't more that compounding pharmacies do not agree with the law as opposed to the claim that there is confusion? Isn't supplying for office use without a patient's name more in line with be a manufacturer? Why or why not? So far there have been very few examples of compounded medications that are need to be kept in a office for emergency use on humans? Most of the examples could be patient specific medications? Why is there now an increase in cost as some claim? Why are compounding pharmacies charging more when the compounds are provided to the patient as opposed to the doctor? What does this indicate?

No comments: